Issue 5/2022
Content (17 Articles)
Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor
Jia Gu, Neng Zhu, Hong-Fang Li, Tan-Jun Zhao, Chan-Juan Zhang, Duan-Fang Liao, Li Qin
A comprehensive review of SHP2 and its role in cancer
Moges Dessale Asmamaw, Xiao-Jing Shi, Li-Rong Zhang, Hong-Min Liu
Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects
Azam Bozorgi, Maryam Bozorgi, Mozafar Khazaei
HDAC6: A unique HDAC family member as a cancer target
Sumeet Kaur, Prerna Rajoria, Madhu Chopra
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer
Alejandro Schcolnik-Cabrera, Daniel Juárez-López
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway
Yunfeng Song, Lei Ye, Yuan Tan, Huan Tong, Zeheng Lv, Xiaoping Wan, Yiran Li
Direct knockdown of phospho-PTM targets mediated by TRIM21 can improve personalized treatment in breast cancer
Pranay Dey, Mansi Joshi, Aaiyas Mujawar, Renu Malhotra, Abhijit De
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
Yi-Zih Kuo, Ya-Rong Kang, Wei-Lun Chang, Lydia Chin-Ling Sim, Tzu-Chin Hsieh, Chu-Han Chang, Yi-Ching Wang, Ching-Jung Tsai, Li-Chun Huang, Sen-Tien Tsai, Li-Wha Wu
Correction to: YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
Yi-Zih Kuo, Ya-Rong Kang, Wei-Lun Chang, Lydia Chin Ling Sim, Tzu-Chin Hsieh, Chu-Han Chang, Yi-Ching Wang, Ching-Jung Tsai, Li-Chun Huang, Sen-Tien Tsai, Li-Wha Wu
Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations
Seul-Ki Choi, Minsuh Kim, Haeseung Lee, Youngjoo Kwon, Hyuk-Jin Cha, Se Jin Jang, Younghwa Na, Yun-Sil Lee
A m6A methyltransferase-mediated immune signature determines prognosis, immune landscape and immunotherapy efficacy in patients with lung adenocarcinoma
Mengyuan Lei, Chenghan Luo, Jiayang Zhang, Wenjun Cao, Jian Ge, Min Zhao
Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer
Shanshan Wang, Taishu Wang, Qianyi Yang, Shaoxuan Cheng, Fang Liu, Guoheng Yang, Fuqiang Wang, Ruilin Wang, Dian Yang, Mingyu Zhou, Chengen Duan, Yingqiu Zhang, Han Liu, Zhaoxia Dai, Kang Tian, Shuyan Liu
Nm23-H1 induces apoptosis in primary effusion lymphoma cells via inhibition of NF-κB signaling through interaction with oncogenic latent protein vFLIP K13 of Kaposi’s sarcoma-associated herpes virus
Suchitra Mohanty, Amit Kumar, Piyanki Das, Sushil Kumar Sahu, Ratnadeep Mukherjee, Rajagopal Ramachandranpillai, Santhosh Sankaran Nair, Tathagata Choudhuri
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models
Janina Fischer-Mertens, Felix Otte, Andrea Roderwieser, Carolina Rosswog, Yvonne Kahlert, Lisa Werr, Anna-Maria Hellmann, Maya Berding, Bill Chiu, Christoph Bartenhagen, Matthias Fischer
Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines
Sen Zhang, Jun Liu, Zi-Yi Lu, Yu-Tong Xue, Xing-Ru Mu, Yang Liu, Jiang Cao, Zhen-Yu Li, Feng Li, Kai-Lin Xu, Qing-Yun Wu
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
Linfeng Xian, Pei Zhao, Xi Chen, Zhimin Wei, Hongxiang Ji, Jun Zhao, Wenbin Liu, Zishuai Li, Donghong Liu, Xue Han, Youwen Qian, Hui Dong, Xiong Zhou, Junyan Fan, Xiaoqiong Zhu, Jianhua Yin, Xiaojie Tan, Dongming Jiang, Hongping Yu, Guangwen Cao
Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer
Zhenyu Zhou, Yaorong Peng, Xiaoying Wu, Shiyu Meng, Wei Yu, Jinghua Zhao, Heyun Zhang, Jie Wang, Wenbin Li